Citations (116)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (22)
Michele Figus, Luca Agnifili, Manuela Lanzini, Lorenza Brescia, Francesco Sartini, Leonardo Mastropasqua & Chiara Posarelli. (2021) Topical preservative-free ophthalmic treatments: an unmet clinical need. Expert Opinion on Drug Delivery 18:6, pages 655-672.
Read now
Read now
Joon Mo Kim, Tae-Woo Kim, Sang-Woo Park, Hae-Young Lopilly Park, Young Hoon Hwang, Jin Wook Jeoung & Chan Yun Kim. (2021) Comparison of the Intraocular Pressure-Lowering Effect and Safety of Preservative-Free And Preservative-Containing Brimonidine/Timolol Fixed-Combination Ophthalmic Solutions in Patients with Open-Angle Glaucoma. Seminars in Ophthalmology 36:3, pages 103-109.
Read now
Read now
Karen Walsh & Lyndon Jones. (2019) The use of preservatives in dry eye drops. Clinical Ophthalmology 13, pages 1409-1425.
Read now
Read now
Pelin Özyol, Erhan Özyol & Aylin Karalezli. (2018) Evaluation of Visual Field Test Parameters after Artificial Tear Administration in Patients with Glaucoma and Dry Eye. Seminars in Ophthalmology 33:3, pages 320-324.
Read now
Read now
Martina Cristaldi, Melania Olivieri, Gabriella Lupo, Carmelina D. Anfuso, Salvatore Pezzino & Dario Rusciano. (2018) N-hydroxymethylglycinate with EDTA is an efficient eye drop preservative with very low toxicity: an in vitro comparative study. Cutaneous and Ocular Toxicology 37:1, pages 71-76.
Read now
Read now
Alberto Aguayo Bonniard, Jacky Y. Yeung, Clara C. Chan & Catherine M. Birt. (2016) Ocular surface toxicity from glaucoma topical medications and associated preservatives such as benzalkonium chloride (BAK). Expert Opinion on Drug Metabolism & Toxicology 12:11, pages 1279-1289.
Read now
Read now
Masamichi Fukuda, Shinsuke Shibata, Naoko Shibata, Kenta Hagihara, Hiromoto Yaguchi, Hiromi Osada, Nobuo Takahashi, Eri Kubo & Hiroshi Sasaki. (2013) Safety comparison of additives in antiglaucoma prostaglandin (PG) analog ophthalmic formulations. Clinical Ophthalmology 7, pages 515-520.
Read now
Read now
Sıtkı Samet Ermiş. (2012) Differential pharmacology and clinical utility of preservative-free tafluprost in the treatment of ocular hypertension and glaucoma. Clinical Ophthalmology 6, pages 673-678.
Read now
Read now
Stefano Ranno, Paolo Fogagnolo, Luca Rossetti, Nicola Orzalesi & Paolo Nucci. (2011) Changes in corneal parameters at confocal microscopy in treated glaucoma patients. Clinical Ophthalmology 5, pages 1037-1042.
Read now
Read now
Françoise Brignole-Baudouin, Luisa Riancho, Hong Liang & Christophe Baudouin. (2011) Comparative In Vitro Toxicology Study of Travoprost Polyquad-preserved, Travoprost BAK-preserved, and Latanoprost BAK-preserved Ophthalmic Solutions on Human Conjunctival Epithelial Cells. Current Eye Research 36:11, pages 979-988.
Read now
Read now
William C. Stewart, Jeanette A. Stewart & Lindsay A. Nelson. (2011) Ocular Surface Disease in Patients with Ocular Hypertension and Glaucoma. Current Eye Research 36:5, pages 391-398.
Read now
Read now
Philippe Denis. (2011) Travoprost/timolol fixed combination in the management of open-angle glaucoma: a clinical review. Expert Opinion on Pharmacotherapy 12:3, pages 463-471.
Read now
Read now
Takeo Fukuchi, Kimiko Wakai, Kieko Suda, Tomoko Nakatsue, Hideko Sawada, Hiroaki Hara, Jun Ueda, Takayuki Tanaka, Akiko Yamada & Haruki Abe. (2010) Incidence, severity and factors related to drug-induced keratoepitheliopathy with glaucoma medications. Clinical Ophthalmology 4, pages 203-209.
Read now
Read now
Dorota Pozarowska. (2010) Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension. Clinical Ophthalmology 4, pages 1229-1236.
Read now
Read now
Masahiko Ayaki, Atsuo Iwasawa & Yoichi Inoue. (2010) Toxicity of antiglaucoma drugs with and without benzalkonium chloride to cultured human corneal endothelial cells. Clinical Ophthalmology 4, pages 1217-1222.
Read now
Read now
Andrey Zhivov, Robert Kraak, Hartwig Bergter, Günther Kundt, Ria Beck & Rudolf F. Guthoff. (2010) Influence of Benzalkonium Chloride on Langerhans Cells in Corneal Epithelium and Development of Dry Eye in Healthy Volunteers. Current Eye Research 35:8, pages 762-769.
Read now
Read now
Michael B Horsley & Malik Y Kahook. (2009) Effects of prostaglandin analog therapy on the ocular surface of glaucoma patients. Clinical Ophthalmology 3, pages 291-295.
Read now
Read now
P David Freeman & Malik Y Kahook. (2009) Preservatives in topical ophthalmic medications: historical and clinical perspectives. Expert Review of Ophthalmology 4:1, pages 59-64.
Read now
Read now
Indu Pal Kaur, Shruti Lal, Cheena Rana, Shilpa Kakkar & Harinder Singh. (2009) Ocular preservatives: associated risks and newer options. Cutaneous and Ocular Toxicology 28:3, pages 93-103.
Read now
Read now
Moataz E Gheith, Jason R Mayer, Ghada A Siam, Daniela S Monteiro de Barros, Tricia L Thomas & L Jay Katz. (2008) Managing refractory glaucoma with a fixed combination of bimatoprost (0.03%) and timolol (0.5%). Clinical Ophthalmology 2:1, pages 15-20.
Read now
Read now
Robert J Noecker. (2006) The management of glaucoma and intraocular hypertension: current approaches and recent advances. Therapeutics and Clinical Risk Management 2:2, pages 193-206.
Read now
Read now
Paul R. Ingram, Andrew R. Pitt, Clive G. Wilson, Orest Olejnik & Corinne M. Spickett. (2004) A Comparison of the Effects of Ocular Preservatives on Mammalian and Microbial ATP and Glutathione Levels. Free Radical Research 38:7, pages 739-750.
Read now
Read now
Articles from other publishers (94)
M Vanathi. (2024) Glaucoma and ocular surface. Indian Journal of Ophthalmology 72:3, pages 305-306.
Crossref
Crossref
PR Aswin, Neethu Mohan, Balagiri Sundar, Arvin Kurian Ponnat, Shanthi Radhakrishnan, Subbaiah R Krishnadas & Emily Schehlein. (2024) Outcome of combined trabeculectomy with cataract surgery in patients on prostaglandin analogs and aqueous suppressants. Indian Journal of Ophthalmology 72:3, pages 439-446.
Crossref
Crossref
Giuseppe Suanno, Philippe Fonteyne & Giulio Ferrari. (2023) Neurosensory abnormalities and stability of a mouse model of dry eye disease. Experimental Eye Research 232, pages 109516.
Crossref
Crossref
Judy Weng, Michael K. Fink & Ajay Sharma. (2023) A Critical Appraisal of the Physicochemical Properties and Biological Effects of Artificial Tear Ingredients and Formulations. International Journal of Molecular Sciences 24:3, pages 2758.
Crossref
Crossref
Paulina Chávez-Hurtado, Luciano Pesqueda-Pinedo, Hector A. Ceballos-Delgadillo, Addy Liñán-Segura, Humberto Figueroa-Ponce & Juan D. Quintana-Hau. (2022) Physicochemical characterization of a DMPC-based nanoemulsion for dry eye and compatibility test with soft contact lenses in vitro. Contact Lens and Anterior Eye 45:2, pages 101428.
Crossref
Crossref
Qiqi Li, Xianggen Wu & Meng Xin. (2021) Strengthened rebamipide ocular nanoformulation to effectively treat corneal alkali burns in mice through the HMGB1 signaling pathway. Experimental Eye Research 213, pages 108824.
Crossref
Crossref
Sushila Bhattarai, Dhayaneethie Perumal, Michael J. Rathbone, Craig R. Bunt & Raid G. Alany. (2021) On the Biocompatibility and Teat Retention of In Situ Gelling Intramammary Formulations: Cattle Mastitis Prevention and Treatment. Pharmaceutics 13:10, pages 1732.
Crossref
Crossref
Romain Magny, Anne Regazzetti, Karima Kessal, Christophe Baudouin, Stéphane Mélik-Parsadaniantz, Olivier Laprévote, Françoise Brignole-Baudouin, Nicolas Auzeil & Emmanuel Roulland. (2021) Deepening of lipidome annotation by associating cross-metathesis reaction with mass spectrometry: application to an in vitro model of corneal toxicity. Analytical and Bioanalytical Chemistry 413:19, pages 4825-4836.
Crossref
Crossref
Guo-Jian Jiang, Bei-Bei Li & Ting-Jun Fan. (2021) Timolol induces necroptosis, apoptosis and senescence concentration-dependently in rabbit Limbal stem cells in vitro. Life Sciences 277, pages 119453.
Crossref
Crossref
Hyun Joo Kee, Eun Jung Lee, Jong Chul Han & Changwon Kee. (2021) Ahmed implant coated with poly(2-methacryloyloxyethyl phosphorylcholine) inhibits foreign body reactions in rabbit eyes. PLOS ONE 16:5, pages e0252467.
Crossref
Crossref
Avani Kathuria, Kiumars Shamloo, Vishal Jhanji & Ajay Sharma. (2021) Categorization of Marketed Artificial Tear Formulations Based on Their Ingredients: A Rational Approach for Their Use. Journal of Clinical Medicine 10:6, pages 1289.
Crossref
Crossref
Nobuo TakedaMasamichi FukudaHiroshi SasakiKazuhisa Sugiyama. (2021) The Effects of Antiglaucoma Ophthalmic Solutions on the Cornea Revealed by a Corneal Electrical Resistance Device. Journal of Ocular Pharmacology and Therapeutics 37:2, pages 97-103.
Crossref
Crossref
Ioannis Halkiadakis, Anna Vernikou, Vasilis Tzimis, Ioannis Markopoulos, Korina Popeskou & Vasiliki Konstadinidou. (2021) Assessment of Corneal Epithelium Thickness in Glaucomatous Patients Undergoing Medical Treatment. Journal of Glaucoma 30:1, pages 44-49.
Crossref
Crossref
Ruiz Simonato Alonso, Helena Parente Solari, Eduardo de França Damasceno, Miguel Noel Nascentes BurnierJr.Jr. & Marcelo Palis Ventura. (2020) The chemotactic properties of various topical brimonidine tartrate ophthalmic preparations. BMC Pharmacology and Toxicology 21:1.
Crossref
Crossref
Romain Magny, Karima Kessal, Anne Regazzetti, Asma Ben Yedder, Christophe Baudouin, Stéphane Mélik Parsadaniantz, Françoise Brignole-Baudouin, Olivier Laprévote & Nicolas Auzeil. (2020) Lipidomic analysis of epithelial corneal cells following hyperosmolarity and benzalkonium chloride exposure: New insights in dry eye disease. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1865:9, pages 158728.
Crossref
Crossref
Sergio Esteban-Pérez, Vanessa Andrés-Guerrero, José Javier López-Cano, Irene Molina-Martínez, Rocio Herrero-Vanrell & Irene Bravo-Osuna. (2020) Gelatin Nanoparticles-HPMC Hybrid System for Effective Ocular Topical Administration of Antihypertensive Agents. Pharmaceutics 12:4, pages 306.
Crossref
Crossref
Pierre-Louis Destruel, Ni Zeng, Johanne Seguin, Sophie Douat, Frédéric Rosa, Françoise Brignole-Baudouin, Sophie Dufaÿ, Amélie Dufaÿ-Wojcicki, Marc Maury, Nathalie Mignet & Vincent Boudy. (2020) Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time. International Journal of Pharmaceutics 574, pages 118734.
Crossref
Crossref
Sung Il Kim, Choul Yong Park, Gladys Fordjuor, Jong Heon Lee, Jong Soo Lee & Ji Eun Lee. (2019) Comparison of cytotoxicities and anti-allergic effects of topical ocular dual-action anti-allergic agents. BMC Ophthalmology 19:1.
Crossref
Crossref
Gloria Roberti, Lucia Tanga, Gianluca Manni, Ivano Riva, Alice Chandra Verticchio, Francesca Berardo, Carmela Carnevale & Francesco Oddone. (2019) Tear Film, Conjunctival and Corneal Modifications Induced by Glaucoma Treatment. Current Medicinal Chemistry 26:22, pages 4253-4261.
Crossref
Crossref
Harinder Singh Sethi, Sugourab Das, Mayuresh P. Naik & Rajshekhar Vemparala. (2018) BKC and CME: Is benzalkonium chloride hindering our efforts to achieve the desired postoperative visual acuity?. International Ophthalmology 39:9, pages 2129-2136.
Crossref
Crossref
James J. Armstrong, Blayne K. Welk, Jennifer N.S. Reid, Vinay Kansal & Cindy M.L. Hutnik. (2019) Secondary surgical intervention after primary glaucoma filtration surgery: an Ontario population-based study. Canadian Journal of Ophthalmology 54:2, pages 212-222.
Crossref
Crossref
V. P. Erichev, S. Yu. Petrov, A. V. Volzhanin & S. A. Ghazaryan. (2019) Continuous anti-glaucoma drug therapy as a risk factor of dry eye. Vestnik oftal'mologii 135:6, pages 117.
Crossref
Crossref
Dörte von Deylen, Christina Dreher, Oliver Seidelmann & Stephan Reichl. (2018) New Classes of Polycationic Compounds as Preservatives for Ophthalmic Formulations. Pharmaceutical Research 36:1.
Crossref
Crossref
Hung-Chang Chen, Zhi-Yu Chen, Tsung-Jen Wang, Victor Drew, Ching-Li Tseng, Hsu-Wei Fang & Feng-Huei Lin. (2017) Herbal Supplement in a Buffer for Dry Eye Syndrome Treatment. International Journal of Molecular Sciences 18:8, pages 1697.
Crossref
Crossref
Jong Heon LeeJong Soo LeeSujin KimJi Eun Lee. (2017) Comparison of cytotoxicities and wound healing effects of diquafosol tetrasodium and hyaluronic acid on human corneal epithelial cells. The Korean Journal of Physiology & Pharmacology 21:2, pages 189.
Crossref
Crossref
Anna Trzeciecka, J. Jussi Paterno, Elisa Toropainen, Ali Koskela, Lucia Podracka, Eveliina Korhonen, Anu Kauppinen, Kai Kaarniranta & Adrian Smedowski. (2016) Long-term topical application of preservative-free prostaglandin analogues evokes macrophage infiltration in the ocular adnexa. European Journal of Pharmacology 788, pages 12-20.
Crossref
Crossref
Ching-Li Tseng, Ya-Jung Hung, Zhi-Yu Chen, Hsu-Wei Fang & Ko-Hua Chen. (2016) Synergistic Effect of Artificial Tears Containing Epigallocatechin Gallate and Hyaluronic Acid for the Treatment of Rabbits with Dry Eye Syndrome. PLOS ONE 11:6, pages e0157982.
Crossref
Crossref
Xinhan Cui, Jun Xiang, Wenqing Zhu, Anji Wei, Qihua Le, Jianjiang Xu & Xiaodong Zhou. (2016) Vitamin A Palmitate and Carbomer Gel Protects the Conjunctiva of Patients With Long-term Prostaglandin Analogs Application. Journal of Glaucoma 25:6, pages 487-492.
Crossref
Crossref
Makoto Aihara, Yoko Ikeda, Shiro Mizoue, Yoshikuni Arakaki, Naofumi Kita & Satoshi Kobayashi. (2016) Effect of Switching to Travoprost Preserved With SofZia in Glaucoma Patients With Chronic Superficial Punctate Keratitis While Receiving BAK-preserved Latanoprost. Journal of Glaucoma 25:6, pages e610-e614.
Crossref
Crossref
Caitlin Chang, Angela Q Zhang, Dov B Kagan, Hong Liu & Cindy ML Hutnik. (2014) Mechanisms of benzalkonium chloride toxicity in a human trabecular meshwork cell line and the protective role of preservative‐free tafluprost. Clinical & Experimental Ophthalmology 43:2, pages 164-172.
Crossref
Crossref
Noriaki Nagai, Chiaki Yoshioka, Tadatoshi Tanino, Yoshimasa Ito, Norio Okamoto & Yoshikazu Shimomura. (2015) Decrease in Corneal Damage due to Benzalkonium Chloride by the Addition of Mannitol into Timolol Maleate Eye Drops. Journal of Oleo Science 64:7, pages 743-750.
Crossref
Crossref
Sabita M Ittoop, Leonard K Seibold & Malik Y Kahook. 2015. Glaucoma. Glaucoma
593
597
.
A. Chan Hew Wai, P. Becasse, S. Tworski, D. Pradeau & V. Planas. (2014) Optimising concentrations of antimicrobial agents in pharmaceutical preparations: Case of an oral solution of glycerol and an ophthalmic solution containing cysteamine. Annales Pharmaceutiques Fran?aises 72:6, pages 415-421.
Crossref
Crossref
Noriaki Nagai, Yoshimasa Ito, Norio Okamoto & Yoshikazu Shimomura. (2014) A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability. Toxicology 319, pages 53-62.
Crossref
Crossref
Alireza Hedayatfar, Hassan Hashemi, Soheila Asgari & Soon-Phaik Chee. (2014) Comparison of Efficacy and Ocular Surface Toxicity of Topical Preservative-free Methylprednisolone and Preserved Prednisolone in the Treatment of Acute Anterior Uveitis. Cornea 33:4, pages 366-372.
Crossref
Crossref
Paolo Frezzotti, Paolo Fogagnolo, Gentiana Haka, Ilaria Motolese, Michele Iester, Simone A. Bagaglia, Pietro Mittica, Cristina Menicacci, Luca Rossetti & Eduardo Motolese. (2013)
In vivo
confocal microscopy of conjunctiva in preservative‐free timolol 0.1% gel formulation therapy for glaucoma
. Acta Ophthalmologica 92:2.
Crossref
Crossref
Noriaki Nagai, Hikaru Ono, Miho Hashino, Yoshimasa Ito, Norio Okamoto & Yoshikazu Shimomura. (2014) Improved Corneal Toxicity and Permeability of Tranilast by the Preparation of Ophthalmic Formulations Containing Its Nanoparticles. Journal of Oleo Science 63:2, pages 177-186.
Crossref
Crossref
Mustafa Kemal Arici, Dilek Sema Arici, Ayşe Vural Özeç, Ayhan Dursun, Mustafa İlker Toker & Haydar Erdoğan. (2018) Apoptotic Effects of Topical Antiglaucoma Medications on Conjunctival Epithelium in Glaucoma Patients. European Journal of Ophthalmology 24:1, pages 63-70.
Crossref
Crossref
Samir M. Nada, Mohamed S. Elgendy, Mary A. Morcos & Marwa O. Abd El All. (2013) Histological study on conjunctival and corneal reactions in rabbits induced by chronic topical application of latanoprost and travoprost. The Egyptian Journal of Histology 36:1, pages 139-148.
Crossref
Crossref
Jike Song, Hongsheng Bi, Xiaofeng Xie, Junguo Guo, Xingrong Wang & Damei Liu. (2013) Natural borneol enhances geniposide ophthalmic absorption in rabbits. International Journal of Pharmaceutics 445:1-2, pages 163-170.
Crossref
Crossref
Makoto Aihara, Hiromi Oshima & Makoto Araie. (2012) Effects of SofZia‐preserved travoprost and benzalkonium chloride‐preserved latanoprost on the ocular surface – a multicentre randomized single‐masked study. Acta Ophthalmologica 91:1.
Crossref
Crossref
Rajesh K. Rajpal, Lawrence Roel, Raphaele Siou-Mermet & Tara Erb. (2013) Efficacy and safety of loteprednol etabonate 0.5% gel in the treatment of ocular inflammation and pain after cataract surgery. Journal of Cataract and Refractive Surgery 39:2, pages 158-167.
Crossref
Crossref
Adeela Malik & Charles Claoué. (2012) Transport and interaction of cosmetic product material within the ocular surface: Beauty and the beastly symptoms of toxic tears. Contact Lens and Anterior Eye 35:6, pages 247-259.
Crossref
Crossref
Reiko Arita, Kouzo Itoh, Shuji Maeda, Koshi Maeda, Ayumu Furuta, Atsuo Tomidokoro, Makoto Aihara & Shiro Amano. (2012) Comparison of the Long-Term Effects of Various Topical Antiglaucoma Medications on Meibomian Glands. Cornea 31:11, pages 1229-1234.
Crossref
Crossref
D Lockington, E C A Macdonald, P Stewart, D Young, M Caslake & K Ramaesh. (2012) Free radicals and the pH of topical glaucoma medications: a lifetime of ocular chemical injury?. Eye 26:5, pages 734-741.
Crossref
Crossref
Yasar Sakarya, Hüseyin Kurku, Rabia Sakarya, Muammer Ozcimen & Selcuk Kara. (2012) Free Radical Content of Drugs Used in Ophthalmology. Electronic Journal of General Medicine 9:2, pages 85-90.
Crossref
Crossref
Stefano Ranno, Matteo Sacchi, Cinzia Brancato, Daniela Gilardi, Andrea Lembo & Paolo Nucci. (2012) A Prospective Study Evaluating IOP Changes after Switching from a Therapy with Prostaglandin Eye Drops Containing Preservatives to Nonpreserved Tafluprost in Glaucoma Patients. The Scientific World Journal 2012, pages 1-6.
Crossref
Crossref
Cem Mesci, Nihat Aydin & Hasan Hasbi Erbil. (2011) Twenty-four-hour Intraocular Pressure Control With Latanoprost-timolol-fixed Combination Versus Bimatoprost in Patients Who Switched From Timolol. Journal of Glaucoma 20:8, pages 477-481.
Crossref
Crossref
Y Kitazawa, P Smith, N Sasaki, S Kotake, K Bae & Y Iwamoto. (2011) Travoprost 0.004%/timolol 0.5%-fixed combination with and without benzalkonium chloride: a prospective, randomized, doubled-masked comparison of safety and efficacy. Eye 25:9, pages 1161-1169.
Crossref
Crossref
Charles S. Tressler, Richard Beatty & Michael A. Lemp. (2011) Preservative Use in Topical Glaucoma Medications. The Ocular Surface 9:3, pages 140-158.
Crossref
Crossref
David A. Ammar, Robert J. Noecker & Malik Y. Kahook. (2011) Effects of benzalkonium chloride- and polyquad-preserved combination glaucoma medications on cultured human ocular surface cells. Advances in Therapy 28:6, pages 501-510.
Crossref
Crossref
J. Javier Servat & C. Robert Bernardino. (2011) Effects of Common Topical Antiglaucoma Medications on the Ocular Surface, Eyelids and Periorbital Tissue. Drugs & Aging 28:4, pages 267-282.
Crossref
Crossref
H. Chibret. (2011) Toxicité oculaire du benzalkonium. Annales Pharmaceutiques Françaises 69:2, pages 108-115.
Crossref
Crossref
Kazuhide Kawase, Wenzhong Lin, Yumiko Aoyama, Tetsuya Yamamoto, Masamitsu Shimazawa & Hideaki Hara. (2011) Effects of timolol-related ophthalmic solutions on cultured human conjunctival cells. Japanese Journal of Ophthalmology 54:6, pages 615-621.
Crossref
Crossref
D. Vaede, C. Baudouin, J.-M. Warnet & F. Brignole-Baudouin. (2010) Les conservateurs des collyres : vers une prise de conscience de leur toxicité. Journal Français d'Ophtalmologie 33:7, pages 505-524.
Crossref
Crossref
Christophe Baudouin, Antoine Labbé, Hong Liang, Aude Pauly & Françoise Brignole-Baudouin. (2010) Preservatives in eyedrops: The good, the bad and the ugly. Progress in Retinal and Eye Research 29:4, pages 312-334.
Crossref
Crossref
Dorota Pozarowska, Piotr Pozarowski & Zbigniew Darzynkiewicz. (2009) Cytometric assessment of cytostatic and cytotoxic effects of topical glaucoma medications on human epithelial corneal line cells. Cytometry Part B: Clinical Cytometry 78B:2, pages 130-137.
Crossref
Crossref
Barbara Cvenkel, Andreja Nata?a Kopitar & Alojz Ihan. (2010) Inflammatory Molecules in Aqueous Humour and on Ocular Surface and Glaucoma Surgery Outcome. Mediators of Inflammation 2010, pages 1-7.
Crossref
Crossref
David A. Ammar & Malik Y. Kahook. (2009) The effects of combination glaucoma medications on ocular surface epithelial cells. Advances in Therapy 26:10, pages 970-975.
Crossref
Crossref
Kohei Hironaka, Yuta Inokuchi, Yuichi Tozuka, Masamitsu Shimazawa, Hideaki Hara & Hirofumi Takeuchi. (2009) Design and evaluation of a liposomal delivery system targeting the posterior segment of the eye. Journal of Controlled Release 136:3, pages 247-253.
Crossref
Crossref
Gianluca Manni, Phillipe Denis, Paul Chew, Elisabeth D. Sharpe, Silvia Orengo-Nania, Michael A. Coote, Guna Laganovska, Lasma Volksone, Thierry Zeyen, Isabella Filatori, John James & Tin Aung. (2009) The Safety and Efficacy of Brinzolamide 1%/Timolol 0.5% Fixed Combination Versus Dorzolamide 2%/Timolol 0.5% in Patients With Open-angle Glaucoma or Ocular Hypertension. Journal of Glaucoma 18:4, pages 293-300.
Crossref
Crossref
Gianluca Martone, Paolo Frezzotti, Gian Marco Tosi, Claudio Traversi, Vincenzo Mittica, Alex Malandrini, Patrizia Pichierri, Angelo Balestrazzi, Paolo Alfonso Motolese, Ilaria Motolese & Edoardo Motolese. (2009) An In Vivo Confocal Microscopy Analysis of Effects of Topical Antiglaucoma Therapy With Preservative on Corneal Innervation and Morphology. American Journal of Ophthalmology 147:4, pages 725-735.e1.
Crossref
Crossref
M Dutot, H Paillet, C Chaumeil, J-M Warnet & P Rat. (2008) Severe ocular infections with contact lens: role of multipurpose solutions. Eye 23:2, pages 470-476.
Crossref
Crossref
Masahiko Ayaki, Shigeo Yaguchi, Atsuo Iwasawa & Ryohei Koide. (2008) Cytotoxicity of ophthalmic solutions with and without preservatives to human corneal endothelial cells, epithelial cells and conjunctival epithelial cells. Clinical & Experimental Ophthalmology 36:6, pages 553-559.
Crossref
Crossref
Malik Y. Kahook & Robert Noecker. (2008) Quantitative analysis of conjunctival goblet cells after chronic application of topical drops. Advances in Therapy 25:8, pages 743-751.
Crossref
Crossref
M. Ciancaglini, P. Carpineto, L. Agnifili, M. Nubile, V. Fasanella, M. Lanzini, R. Calienno & L. Mastropasqua. (2018) An in Vivo Confocal Microscopy and Impression Cytology Analysis of Preserved and Unpreserved Levobunolol-Induced Conjunctival Changes. European Journal of Ophthalmology 18:3, pages 400-407.
Crossref
Crossref
Mélody Dutot, Jean-Michel Warnet, Christophe Baudouin & Patrice Rat. (2008) Cytotoxicity of contact lens multipurpose solutions: Role of oxidative stress, mitochondrial activity and P2X7 cell death receptor activation. European Journal of Pharmaceutical Sciences 33:2, pages 138-145.
Crossref
Crossref
Denise K. Chun, Aron Shapiro & Mark B. Abelson. 2008. Albert & Jakobiec's Principles & Practice of Ophthalmology. Albert & Jakobiec's Principles & Practice of Ophthalmology
179
192
.
Yuka Okada. (2007) Effects of Topical Antiglaucoma Medications on Corneal Epithelium as Evaluated by Gene Expression Patterns. Cornea 26:Supplement 1, pages S46-S54.
Crossref
Crossref
Fabio Coppedè, Renato Colognato, Alessia Bonelli, Guja Astrea, Stefania Bargagna, Gabriele Siciliano & Lucia Migliore. (2007) Polymorphisms in folate and homocysteine metabolizing genes and chromosome damage in mothers of Down syndrome children. American Journal of Medical Genetics Part A 143A:17, pages 2006-2015.
Crossref
Crossref
C. Baudouin. (2018) Ocular Surface Assessment of Glaucoma Drug Tolerance. European Journal of Ophthalmology 17:5_suppl, pages 18-21.
Crossref
Crossref
C. Traverso. (2018) Combination Products for Glaucoma: An Overview of Treatment Principles. European Journal of Ophthalmology 17:5_suppl, pages 5-8.
Crossref
Crossref
N. Jaenen, C. Baudouin, P. Pouliquen, G. Manni, A. Figueiredo & T. Zeyen. (2018) Ocular Symptoms and Signs with Preserved and Preservative-Free Glaucoma Medications. European Journal of Ophthalmology 17:3, pages 341-349.
Crossref
Crossref
. (2007) The Definition and Classification of Dry Eye Disease: Report of the Definition and Classification Subcommittee of the International Dry Eye Workshop (2007). The Ocular Surface 5:2, pages 75-92.
Crossref
Crossref
Aude Pauly, Françoise Brignole-Baudouin, Jean-Marc Guenoun, Luisa Riancho, Patrice Rat, Jean-Michel Warnet & Christophe Baudouin. (2006) Comparative study of topical anti-allergic eye drops on human conjunctiva-derived cells: responses to histamine and IFNγ and toxicological profiles. Graefe's Archive for Clinical and Experimental Ophthalmology 245:4, pages 534-546.
Crossref
Crossref
Richard W Yee. (2007) The effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: a review. Current Opinion in Ophthalmology 18:2, pages 134-139.
Crossref
Crossref
Ö Yenice, A Temel & Ö Örüm. (2006) The effect of artificial tear administration on visual field testing in patients with glaucoma and dry eye. Eye 21:2, pages 214-217.
Crossref
Crossref
Gabriel Sosne, Abdul-Rahman Albeiruti, Brian Hollis, Atif Siddiqi, David Ellenberg & Michelle Kurpakus-Wheater. (2006) Thymosin β4 inhibits benzalkonium chloride-mediated apoptosis in corneal and conjunctival epithelial cells in vitro. Experimental Eye Research 83:3, pages 502-507.
Crossref
Crossref
Jess T. Whitson, H. Dwight Cavanagh, Neema Lakshman & W. Matthew Petroll. (2006) Assessment of corneal epithelial integrity after acute exposure to ocular hypotensive agents preserved with and without benzalkonium chloride. Advances in Therapy 23:5, pages 663-671.
Crossref
Crossref
Richard W. Yee, Evan G. Norcom & Xinping C. Zhao. (2006) Comparison of the relative toxicity of travoprost 0.004% without benzalkonium chloride and latanoprost 0.005% in an immortalized human cornea epithelial cell culture system. Advances in Therapy 23:4, pages 511-518.
Crossref
Crossref
Ben L. Mason, Eduardo C. Alfonso & Darlene Miller. (2005) In-use study of potential bacterial contamination of ophthalmic moxifloxacin. Journal of Cataract and Refractive Surgery 31:9, pages 1773-1776.
Crossref
Crossref
Takayuki Kikuchi, Masahiko Suzuki, Akira Kusai, Ken Iseki, Hitoshi Sasaki & Kenichiro Nakashima. (2005) Mechanism of permeability-enhancing effect of EDTA and boric acid on the corneal penetration of 4-[1-hydroxy-1-methylethyl]-2-propyl-1-[4-[2-[tetrazole-5-yl]phenyl]phenyl] methylimidazole-5-carboxylic acid monohydrate (CS-088). International Journal of Pharmaceutics 299:1-2, pages 107-114.
Crossref
Crossref
Takayuki Kikuchi, Masahiko Suzuki, Akira Kusai, Ken Iseki & Hitoshi Sasaki. (2005) Synergistic effect of EDTA and boric acid on corneal penetration of CS-088. International Journal of Pharmaceutics 290:1-2, pages 83-89.
Crossref
Crossref
Penny A. Asbell & Natalia Potapova. (2005) Effects of Topical Antiglaucoma Medications on the Ocular Surface. The Ocular Surface 3:1, pages 27-40.
Crossref
Crossref
Robert J Noecker, Lisa A Herrygers & Raana Anwaruddin. (2004) Corneal and Conjunctival Changes Caused by Commonly Used Glaucoma Medications. Cornea 23:5, pages 490-496.
Crossref
Crossref
Shinji Hirano, Takeshi Sagara, Katsuyoshi Suzuki, Keisuke Seki & Teruo Nishida. (2004) Inhibitory Effects of Anti-Glaucoma Drugs on Corneal Epithelial Migration in a Rabbit Organ Culture System. Journal of Glaucoma 13:3, pages 196-199.
Crossref
Crossref
M De Saint Jean, C Baudouin, M Di Nolfo, S Roman, P Lozato, J.M Warnet & F Brignole. (2004) Comparison of morphological and functional characteristics of primary-cultured human conjunctival epithelium and of Wong–Kilbourne derivative of Chang conjunctival cell line. Experimental Eye Research 78:2, pages 257-274.
Crossref
Crossref
Takeshi Ishibashi, Norihiko Yokoi & Shigeru Kinoshita. (2003) Comparison of the Short-Term Effects on the Human Corneal Surface of Topical Timolol Maleate With and Without Benzalkonium Chloride. Journal of Glaucoma 12:6, pages 486-490.
Crossref
Crossref
F Brignole-Baudouin. (2003) La cytométrie en flux appliquée à l’exploration des pathologies de la surface oculaire. Immuno-analyse & Biologie Spécialisée 18:6, pages 341-349.
Crossref
Crossref
Thomas Mundorf, Katrina A. Wilcox, George W. Ousler, Donna Welch & Mark B. Abelson. (2003) Evaluation of the comfort of Alphagan® P compared with Alphagan® in irritated eyes. Advances in Therapy 20:6, pages 329-336.
Crossref
Crossref
Sébastien Perrot, Hélène Dutertre‐Catella, Chantal Martin, Jean‐Michel Warnet & Patrice Rat. (2003) A new nondestructive cytometric assay based on resazurin metabolism and an organ culture model for the assessment of corneal viability. Cytometry Part A 55A:1, pages 7-14.
Crossref
Crossref
L. Jay Katz. (2002) Twelve-Month Evaluation of Brimonidine-Purite Versus Brimonidine in Patients With Glaucoma or Ocular Hypertension. Journal of Glaucoma 11:2, pages 119-126.
Crossref
Crossref
C Baudouin. (2002) Pathologie iatrog?ne de la conjonctive et de la corn?e. Revue Fran?aise d'Allergologie et d'Immunologie Clinique 42:1, pages 79-87.
Crossref
Crossref
Robert Noecker. (2001) Effects of common ophthalmic preservatives on ocular health. Advances in Therapy 18:5, pages 205-215.
Crossref
Crossref